-
1
-
-
0035825042
-
Cancer vaccines
-
Moingeon P. Cancer vaccines. Vaccine. 19:2001;1305-1326.
-
(2001)
Vaccine
, vol.19
, pp. 1305-1326
-
-
Moingeon, P.1
-
3
-
-
0020544784
-
Fixation of Thy-1 in nervous tissue for immunohistochemistry: A quantitative assessment of the effect of different fixation conditions upon retention of antigenicity and the cross-linking of Thy-1
-
Morris R.J., Barber P.C. Fixation of Thy-1 in nervous tissue for immunohistochemistry: a quantitative assessment of the effect of different fixation conditions upon retention of antigenicity and the cross-linking of Thy-1. J. Histochem. Cytochem. 31:1983;263-274.
-
(1983)
J. Histochem. Cytochem.
, vol.31
, pp. 263-274
-
-
Morris, R.J.1
Barber, P.C.2
-
4
-
-
0028912262
-
Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumor sections
-
Liu S.Q., Saijo K., Todoroki T., Ohno T. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumor sections. Nat. Med. 1:1995;267-271.
-
(1995)
Nat. Med.
, vol.1
, pp. 267-271
-
-
Liu, S.Q.1
Saijo, K.2
Todoroki, T.3
Ohno, T.4
-
5
-
-
6844237663
-
Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells
-
Horiuchi K., Tsurushima H., Kim B.S., Liu S.Q., Saijo K., Nukiwa T., Matsumura M., Ohno T. Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells. Cytotechnology. 26:1998;119-124.
-
(1998)
Cytotechnology
, vol.26
, pp. 119-124
-
-
Horiuchi, K.1
Tsurushima, H.2
Kim, B.S.3
Liu, S.Q.4
Saijo, K.5
Nukiwa, T.6
Matsumura, M.7
Ohno, T.8
-
6
-
-
18344392456
-
Autologous fixed tumor vaccine: A formulation with cytokine- microparticles for protective immunity against recurrence of human hepatocellular carcinoma
-
Peng B.G., Liu S.Q., Kuang M., He Q., Totsuka S., Huang L., Huang J.F., Lu M.D., Liang L.J., Leong K.W., Ohno T. Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma. Jpn J. Cancer Res. 93:2002;363-368.
-
(2002)
Jpn J. Cancer Res.
, vol.93
, pp. 363-368
-
-
Peng, B.G.1
Liu, S.Q.2
Kuang, M.3
He, Q.4
Totsuka, S.5
Huang, L.6
Huang, J.F.7
Lu, M.D.8
Liang, L.J.9
Leong, K.W.10
Ohno, T.11
-
7
-
-
0031570461
-
Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state
-
Fujimoto T., Duda R.B., Szilvasi A., Chen X., Mai M., O'Donnell M.A. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J. Immunol. 158:1997;5619-5626.
-
(1997)
J. Immunol.
, vol.158
, pp. 5619-5626
-
-
Fujimoto, T.1
Duda, R.B.2
Szilvasi, A.3
Chen, X.4
Mai, M.5
O'Donnell, M.A.6
-
8
-
-
0032412510
-
OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients
-
Takahashi K., Harauchi D., Kimura S., Saito S., Monden Y. OK-432 develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients. Int. J. Immunopharmacol. 20:1998;375-388.
-
(1998)
Int. J. Immunopharmacol.
, vol.20
, pp. 375-388
-
-
Takahashi, K.1
Harauchi, D.2
Kimura, S.3
Saito, S.4
Monden, Y.5
-
9
-
-
0035008881
-
Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer
-
Sakamoto J., Teramukai S., Watanabe Y., Hayata Y., Okayasu T., Nakazato H., Ohashi Y. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer. J. Immunother. 24:2001;250-256.
-
(2001)
J. Immunother.
, vol.24
, pp. 250-256
-
-
Sakamoto, J.1
Teramukai, S.2
Watanabe, Y.3
Hayata, Y.4
Okayasu, T.5
Nakazato, H.6
Ohashi, Y.7
-
10
-
-
0033136213
-
Purified protein derivative (PPD) as an immunogen carrier elicits high antigen specificity to haptens
-
De Silva B.S., Egodage K.L., Wilson G.S. Purified protein derivative (PPD) as an immunogen carrier elicits high antigen specificity to haptens. Bioconjug. Chem. 10:1999;496-501.
-
(1999)
Bioconjug. Chem.
, vol.10
, pp. 496-501
-
-
De Silva, B.S.1
Egodage, K.L.2
Wilson, G.S.3
-
12
-
-
0019488598
-
Importance of antigen-lymphocyte interaction in establishment of cellular immunity
-
Naito M., Seno S. Importance of antigen-lymphocyte interaction in establishment of cellular immunity. Cell Biol. Int. Rep. 5:1981;675-681.
-
(1981)
Cell Biol. Int. Rep.
, vol.5
, pp. 675-681
-
-
Naito, M.1
Seno, S.2
-
13
-
-
0034255724
-
+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
-
+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. Int. J. Cancer. 87:2000;391-398.
-
(2000)
Int. J. Cancer
, vol.87
, pp. 391-398
-
-
Lewis, J.J.1
Janetzki, S.2
Schaed, S.3
Panageas, K.S.4
Wang, S.5
Williams, L.6
Meyers, M.7
Butterworth, L.8
Livingston, P.O.9
Chapman, P.B.10
Houghton, A.N.11
-
14
-
-
0032573225
-
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
-
Soiffer R., Lynch T., Mihm M., Jung K., Rhuda C., Schmollinger J.C., Hodi F.S., Liebster L., Lam P., Mentzer S., Singer S., Tanabe K.K., Cosimi A.B., Duda R., Sober A., Bhan A., Daley J., Neuberg D., Parry G., Rokovich J., Richards L., Drayer J., Berns A., Clift S., Cohen L.K., Mulligan R.C., Dranoff G. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA. 95:1998;13141-13146.
-
(1998)
Proc. Natl Acad. Sci. USA
, vol.95
, pp. 13141-13146
-
-
Soiffer, R.1
Lynch, T.2
Mihm, M.3
Jung, K.4
Rhuda, C.5
Schmollinger, J.C.6
Hodi, F.S.7
Liebster, L.8
Lam, P.9
Mentzer, S.10
Singer, S.11
Tanabe, K.K.12
Cosimi, A.B.13
Duda, R.14
Sober, A.15
Bhan, A.16
Daley, J.17
Neuberg, D.18
Parry, G.19
Rokovich, J.20
Richards, L.21
Drayer, J.22
Berns, A.23
Clift, S.24
Cohen, L.K.25
Mulligan, R.C.26
Dranoff, G.27
more..
-
15
-
-
0033782775
-
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
-
Wei Y.Q., Wang Q.R., Zhao X., Yang L., Tian L., Lu Y., Kang B., Lu C.J., Huang M.J., Lou Y.Y., Xiao F., He Q.M., Shu J.M., Xie X.J., Mao Y.Q., Lei S., Luo F., Zhou L.Q., Liu C.E., Zhou H., Jiang Y., Peng F., Yuan L.P., Li Q., Wu Y., Liu J.Y. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat. Med. 6:2000;1160-1166.
-
(2000)
Nat. Med.
, vol.6
, pp. 1160-1166
-
-
Wei, Y.Q.1
Wang, Q.R.2
Zhao, X.3
Yang, L.4
Tian, L.5
Lu, Y.6
Kang, B.7
Lu, C.J.8
Huang, M.J.9
Lou, Y.Y.10
Xiao, F.11
He, Q.M.12
Shu, J.M.13
Xie, X.J.14
Mao, Y.Q.15
Lei, S.16
Luo, F.17
Zhou, L.Q.18
Liu, C.E.19
Zhou, H.20
Jiang, Y.21
Peng, F.22
Yuan, L.P.23
Li, Q.24
Wu, Y.25
Liu, J.Y.26
more..
-
16
-
-
0004357220
-
Immuno-protective effect of tumor cell vaccine on Kunming mice bearing Ehrlich ascites tumor
-
Ma Z., Zhou S.J., Wu K.C., Pan B.R., Qiao T.D., Chen B.J., Fan D.M. Immuno-protective effect of tumor cell vaccine on Kunming mice bearing Ehrlich ascites tumor. World J. Gastroenterol. 4:1998;404-408.
-
(1998)
World J. Gastroenterol.
, vol.4
, pp. 404-408
-
-
Ma, Z.1
Zhou, S.J.2
Wu, K.C.3
Pan, B.R.4
Qiao, T.D.5
Chen, B.J.6
Fan, D.M.7
-
17
-
-
0037093854
-
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
-
Dredge K., Marriott J.B., Todryk S.M., Muller G.W., Chen R., Stirling D.I., Dalgleish A.G. Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. J. Immunol. 168:2002;4914-4919.
-
(2002)
J. Immunol.
, vol.168
, pp. 4914-4919
-
-
Dredge, K.1
Marriott, J.B.2
Todryk, S.M.3
Muller, G.W.4
Chen, R.5
Stirling, D.I.6
Dalgleish, A.G.7
-
18
-
-
0033589811
-
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors
-
Ji H., Wang T.L., Chen C.H., Pai S.I., Hung C.F., Lin K.Y., Kurman R.J., Pardoll D.M., Wu T.C. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum. Gene Ther. 10:1999;2727-2740.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 2727-2740
-
-
Ji, H.1
Wang, T.L.2
Chen, C.H.3
Pai, S.I.4
Hung, C.F.5
Lin, K.Y.6
Kurman, R.J.7
Pardoll, D.M.8
Wu, T.C.9
|